Presented by Nedret Emiroglu, Deputy Director, Division of Communicable Diseases, Health Security and Environment, WHO/Europe, at the 64th session of the WHO Regional Committee for Europe.
Presentation delivered by Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
This document proposes a new approach for assessing and monitoring implementation of the International Health Regulations (2005) in the WHO Eastern Mediterranean Region. The new approach includes establishing an Independent IHR Regional Assessment Commission to oversee IHR implementation in the region, identify priority issues, and report annually to the Regional Committee. It also calls for establishing an IHR Regional Task Force composed of WHO and other agency experts to support IHR implementation, gather evidence for the Commission, and advise on strategies. The approach is meant to improve upon solely relying on country self-evaluations by combining them with peer review and voluntary external evaluations.
Presentation delivered by Mr Imre Holl, Director, Planning Resource Coordination and Performance Monitoring, WHO, at the 67th session of the WHO Regional Committee for Europe
The Programme Subcommittee held three meetings in 2021 to discuss the agenda and preparations for the 68th session of the WHO Regional Committee for the Eastern Mediterranean. The Subcommittee, composed of representatives from various member states, reviewed proposals, approved the initial agenda, and agreed to hold the 68th session virtually due to the COVID-19 pandemic. At its final meeting, the Subcommittee noted the progress made in implementing resolutions from the previous Regional Committee session and discussed upcoming membership changes.
The document reports on progress implementing the International Health Regulations (2005) in the WHO Eastern Mediterranean Region. Joint external evaluations in 6 countries identified major gaps in core IHR capacities. These include insufficient support for national IHR focal points, limited coordination mechanisms, and gaps in surveillance and emergency preparedness. An independent regional assessment commission reviewed implementation and advised strengthening multisectoral collaboration, laboratory networks, and response to chemical/radiation emergencies. A draft WHO global plan outlines actions to accelerate country implementation of IHR and strengthen WHO's capacity to support public health emergency response worldwide. The Regional Committee is invited to note the progress report and provide comments on the draft global implementation plan.
Polio eradication efforts have significantly reduced polio cases worldwide since 1988, but containment of polioviruses remains an ongoing challenge. The WHO recommends poliovirus materials be contained according to phases that began with preparation for poliovirus type 2 containment by 2016. Containment involves inventorying, transferring, and destroying unnecessary materials or nominating essential facilities for certification. While minimizing risk, challenges include the large number of facilities handling potentially infectious materials and balancing containment with vaccine supply. Key resources provide guidance on containment procedures and certification of essential facilities.
The document discusses the development of the WHO's 13th General Programme of Work (GPW13) Results Framework for measuring impact. It provides an update on progress, including developing 46 outcome indicators and milestones aligned with the six GPW13 themes. It outlines next steps in finalizing the framework through additional member state consultations, establishing baselines and milestones, and reporting to the Executive Board and World Health Assembly. The goal is to obtain joint commitment for implementing the framework to measure GPW13 progress and impact.
The document discusses ECDC's strategy for laboratory external quality assessment (EQA) schemes from 2017 to 2020. It notes that EQA schemes face limited resources and must adapt to new technologies like whole genome sequencing. The strategy aims to prioritize EQA schemes based on supporting new methods, emerging diseases, molecular typing, and harmonization. It sets objectives to increase country participation, improve reporting, link EQAs to capacity building, and monitor usefulness. The strategy proposes including EQA participation in the European Union Laboratory Capability Monitoring framework.
Presentation delivered by Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
This document proposes a new approach for assessing and monitoring implementation of the International Health Regulations (2005) in the WHO Eastern Mediterranean Region. The new approach includes establishing an Independent IHR Regional Assessment Commission to oversee IHR implementation in the region, identify priority issues, and report annually to the Regional Committee. It also calls for establishing an IHR Regional Task Force composed of WHO and other agency experts to support IHR implementation, gather evidence for the Commission, and advise on strategies. The approach is meant to improve upon solely relying on country self-evaluations by combining them with peer review and voluntary external evaluations.
Presentation delivered by Mr Imre Holl, Director, Planning Resource Coordination and Performance Monitoring, WHO, at the 67th session of the WHO Regional Committee for Europe
The Programme Subcommittee held three meetings in 2021 to discuss the agenda and preparations for the 68th session of the WHO Regional Committee for the Eastern Mediterranean. The Subcommittee, composed of representatives from various member states, reviewed proposals, approved the initial agenda, and agreed to hold the 68th session virtually due to the COVID-19 pandemic. At its final meeting, the Subcommittee noted the progress made in implementing resolutions from the previous Regional Committee session and discussed upcoming membership changes.
The document reports on progress implementing the International Health Regulations (2005) in the WHO Eastern Mediterranean Region. Joint external evaluations in 6 countries identified major gaps in core IHR capacities. These include insufficient support for national IHR focal points, limited coordination mechanisms, and gaps in surveillance and emergency preparedness. An independent regional assessment commission reviewed implementation and advised strengthening multisectoral collaboration, laboratory networks, and response to chemical/radiation emergencies. A draft WHO global plan outlines actions to accelerate country implementation of IHR and strengthen WHO's capacity to support public health emergency response worldwide. The Regional Committee is invited to note the progress report and provide comments on the draft global implementation plan.
Polio eradication efforts have significantly reduced polio cases worldwide since 1988, but containment of polioviruses remains an ongoing challenge. The WHO recommends poliovirus materials be contained according to phases that began with preparation for poliovirus type 2 containment by 2016. Containment involves inventorying, transferring, and destroying unnecessary materials or nominating essential facilities for certification. While minimizing risk, challenges include the large number of facilities handling potentially infectious materials and balancing containment with vaccine supply. Key resources provide guidance on containment procedures and certification of essential facilities.
The document discusses the development of the WHO's 13th General Programme of Work (GPW13) Results Framework for measuring impact. It provides an update on progress, including developing 46 outcome indicators and milestones aligned with the six GPW13 themes. It outlines next steps in finalizing the framework through additional member state consultations, establishing baselines and milestones, and reporting to the Executive Board and World Health Assembly. The goal is to obtain joint commitment for implementing the framework to measure GPW13 progress and impact.
The document discusses ECDC's strategy for laboratory external quality assessment (EQA) schemes from 2017 to 2020. It notes that EQA schemes face limited resources and must adapt to new technologies like whole genome sequencing. The strategy aims to prioritize EQA schemes based on supporting new methods, emerging diseases, molecular typing, and harmonization. It sets objectives to increase country participation, improve reporting, link EQAs to capacity building, and monitor usefulness. The strategy proposes including EQA participation in the European Union Laboratory Capability Monitoring framework.
Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis, Dr Masoud Dara, Acting Director, Communicable Diseases Department (69th session of the WHO Regional Committee for Europe)
- The Regional Plan for Implementation (RPI) of the WHO European Region's Programme Budget for 2018-2019 focuses on continuing priorities from the previous biennium with an emphasis on unfinished public health goals. It was developed through bottom-up priority setting with member states and alignment with the Sustainable Development Goals.
- The budget of $261.9 million, a 2% increase from the previous period, will focus on communicable diseases, antimicrobial resistance, priorities set by member states, and the WHO Health Emergencies Programme. Flexible funding will help support underfunded areas and country-level activities.
- Implementation will be measured by benchmarks and programmatic indicators presented to the 68th session of the
This document summarizes the WHO Draft Global Implementation Plan for the International Health Regulations (IHR) from 2005. The plan was requested by the World Health Assembly in 2016 and addresses recommendations from the IHR Review Committee. The draft plan proposes both immediate implementation of recommendations within the existing IHR framework, as well as areas that may require consultation or amendments. It includes 6 areas of action that encompass the committee's 12 major and 60 supporting recommendations. The areas focus on accelerating country implementation, strengthening WHO capacity, improving monitoring and reporting, improving risk assessment and communication, enhancing compliance with temporary recommendations, and rapid sharing of scientific information.
The document summarizes changes to the GP contract regulations and priorities for NHS immunizations in response to COVID-19. It states that the regulations will temporarily amend core hours definitions and increase 111 direct booking minimums. It also suspends requirements like annual reviews, medication reviews, and patient feedback processes. The letter prioritizes routine childhood immunizations as well as targeted vaccines for babies, pregnant women, and those at high risk.
The document summarizes progress made under Ireland's National Action Plan on Antimicrobial Resistance 2017-2020 (iNAP 1) and outlines plans for iNAP 2. It discusses successes in areas like surveillance, guidelines and awareness campaigns. It also notes challenges from COVID-19, which led to delays in developing iNAP 2. Resources have been substantially invested in 2018-2021 to support iNAP 1 goals and respond to COVID-19, including new IPC staff across healthcare settings. Stakeholder engagement for iNAP 2 will begin following scoping of ongoing activities and lessons from COVID-19.
Dr Caroline Brown, Programme Manager, Influenza and Other Respiratory Pathogens, Thomas Hofmann, IHR Area Coordinator, Communicable Diseases and Health Security
Presented by Leen Meulenbergs
WHO Representative to the European Union and
Executive Manager for Strategic Partnerships (PAR) in the WHO European Union, at the 66th Session of the WHO Regional Committee for Europe.
1) The proposed strategic plan focuses on improving preparedness for FMD and similar transboundary animal diseases through better training, emergency preparedness tools, and research.
2) It aims to reduce disease risks in Europe and its neighboring regions through coordinated control programs, improved early warning systems, and building veterinary capacity.
3) A third goal is sustaining global progress against FMD through continued support of the Progressive Control Pathway and improving vaccine access and supply.
Presentation by the Swedish National Audit Office, in English, at the third and last webinar co-organised by SIGMA and the Network of Supreme Audit Institutions of EU candidates and potential candidate countries, held on 28 June 2021. The event explores the audit of COVID-19 related expenditures.
Presented by Oleg Chestnov, Assistant Director-General for Noncommunicable Diseases and Mental Health, WHO, at the 64th session of the WHO Regional Committee for Europe.
This document discusses HPV vaccination in the WHO European Region. It provides data on which countries have introduced the HPV vaccine as of 2011, the criteria used by countries in their decision making, details on routine and catch-up vaccination programs in various countries, and HPV vaccine coverage rates. It also discusses components of successful HPV vaccination programs and the importance of continuing cervical cancer screening programs alongside vaccination.
This document discusses the implementation of the WHO European Region's Health 2020 policy framework from 2012-2014. It outlines two strategic objectives and four common policy priorities for health. It describes moving from developing the policy to taking action by helping countries update their national health policies and improve public health capacities. The document also discusses promoting the framework, building implementation capacity, supporting country cooperation, and exploring new partnerships to advance the goals of Health 2020 across Europe.
Program expenditure classification - Cristina CLASARA, PhilippinesOECD Governance
The document discusses the Program Expenditure Classification Restructuring (PREXC) approach which aims to simplify the budget structure, link planning and budgeting, and measure performance. It does this by grouping all recurring activities and projects under the programs they contribute to and providing performance indicators for each program objective. This shifts the focus from line-item inputs to the intended outcomes of allocations. It also defines what constitutes a program and provides an example comparing the old and PREXC structures, showing how the PREXC approach organizes budget items by program and associated outcome indicators.
Programme budgeting for health - Edwin Lau, OECD SecretariatOECD Governance
This presentation was made by Edwin Lau, OECD Secretariat, at the 7th meeting of the Joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held at the OECD Conference Centre, Paris, on 14-15 February 2019
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe at the South-eastern Europe Health Ministerial Meeting on Immunization in Podgorica, Montenegro, 20 February 2018
THE GF-TADs INITIATIVE FOR THE GLOBAL CONTROL OF AFRICAN SWINE FEVEREuFMD
African swine fever (ASF) is an infectious disease affecting pigs that has spread globally and poses a major threat to animal health, economies, and food security. The World Organisation for Animal Health and Food and Agriculture Organization of the United Nations developed a Global Initiative to control ASF between 2020-2025 using a theory of change, logical framework, and operational plan. The initiative aims to support global coordination in ASF control through activities implemented under the Global Framework for Transboundary Animal Diseases. Regional expert groups will also play a key role, with continued investment in veterinary services and surveillance needed to feasibly control ASF globally over the long term.
Holmgren redd+ monitoring and information overview 21 march 2011 finaltheREDDdesk
The document discusses monitoring and information requirements for REDD+ programs. It outlines that monitoring is key to meeting UNFCCC requirements, serving national policy needs, and ensuring effective local implementation. Monitoring needs to assess carbon emissions, environmental and social impacts, and governance. Strategic monitoring requires high accuracy while operational monitoring needs full coverage at low cost. The UN-REDD program will develop a monitoring framework and package of tools to support country-level REDD+ monitoring efforts.
TOPIC 1 IMUNIZATION SYSTEMS AND OPERATIONS.pdfChisupa
The document discusses the Expanded Programme on Immunization (EPI), which aims to eradicate and eliminate vaccine-preventable diseases through vaccination programs. It describes the goals and components of EPI, including vaccines, cold chain storage, service delivery, disease surveillance, and social mobilization. The key operations of immunization systems are outlined as vaccine supply and quality, logistics, service delivery, surveillance, and communication. Supporting components that sustain immunization operations are management, sustainable financing, and strengthening human and institutional resources.
This document summarizes discussions from a microbiology focal points meeting on health threats and preparedness. Key points include:
1) The European Social Fund Plus for 2021-2027 aims to strengthen crisis preparedness and response to cross-border health threats.
2) Joint actions like SHARP work to improve implementation of the International Health Regulations and enhance laboratory capacity for detecting pathogens.
3) The Horizon Europe programme will support research and innovation to develop new therapies and diagnostics for infectious diseases.
4) Various Commission DGs are collaborating on initiatives related to laboratory networks, digital health, biosafety, and security to improve EU preparedness for health emergencies.
Progress in and priorities for implementing the regional plans for the health sector response to HIV and hepatitis, Dr Masoud Dara, Acting Director, Communicable Diseases Department (69th session of the WHO Regional Committee for Europe)
- The Regional Plan for Implementation (RPI) of the WHO European Region's Programme Budget for 2018-2019 focuses on continuing priorities from the previous biennium with an emphasis on unfinished public health goals. It was developed through bottom-up priority setting with member states and alignment with the Sustainable Development Goals.
- The budget of $261.9 million, a 2% increase from the previous period, will focus on communicable diseases, antimicrobial resistance, priorities set by member states, and the WHO Health Emergencies Programme. Flexible funding will help support underfunded areas and country-level activities.
- Implementation will be measured by benchmarks and programmatic indicators presented to the 68th session of the
This document summarizes the WHO Draft Global Implementation Plan for the International Health Regulations (IHR) from 2005. The plan was requested by the World Health Assembly in 2016 and addresses recommendations from the IHR Review Committee. The draft plan proposes both immediate implementation of recommendations within the existing IHR framework, as well as areas that may require consultation or amendments. It includes 6 areas of action that encompass the committee's 12 major and 60 supporting recommendations. The areas focus on accelerating country implementation, strengthening WHO capacity, improving monitoring and reporting, improving risk assessment and communication, enhancing compliance with temporary recommendations, and rapid sharing of scientific information.
The document summarizes changes to the GP contract regulations and priorities for NHS immunizations in response to COVID-19. It states that the regulations will temporarily amend core hours definitions and increase 111 direct booking minimums. It also suspends requirements like annual reviews, medication reviews, and patient feedback processes. The letter prioritizes routine childhood immunizations as well as targeted vaccines for babies, pregnant women, and those at high risk.
The document summarizes progress made under Ireland's National Action Plan on Antimicrobial Resistance 2017-2020 (iNAP 1) and outlines plans for iNAP 2. It discusses successes in areas like surveillance, guidelines and awareness campaigns. It also notes challenges from COVID-19, which led to delays in developing iNAP 2. Resources have been substantially invested in 2018-2021 to support iNAP 1 goals and respond to COVID-19, including new IPC staff across healthcare settings. Stakeholder engagement for iNAP 2 will begin following scoping of ongoing activities and lessons from COVID-19.
Dr Caroline Brown, Programme Manager, Influenza and Other Respiratory Pathogens, Thomas Hofmann, IHR Area Coordinator, Communicable Diseases and Health Security
Presented by Leen Meulenbergs
WHO Representative to the European Union and
Executive Manager for Strategic Partnerships (PAR) in the WHO European Union, at the 66th Session of the WHO Regional Committee for Europe.
1) The proposed strategic plan focuses on improving preparedness for FMD and similar transboundary animal diseases through better training, emergency preparedness tools, and research.
2) It aims to reduce disease risks in Europe and its neighboring regions through coordinated control programs, improved early warning systems, and building veterinary capacity.
3) A third goal is sustaining global progress against FMD through continued support of the Progressive Control Pathway and improving vaccine access and supply.
Presentation by the Swedish National Audit Office, in English, at the third and last webinar co-organised by SIGMA and the Network of Supreme Audit Institutions of EU candidates and potential candidate countries, held on 28 June 2021. The event explores the audit of COVID-19 related expenditures.
Presented by Oleg Chestnov, Assistant Director-General for Noncommunicable Diseases and Mental Health, WHO, at the 64th session of the WHO Regional Committee for Europe.
This document discusses HPV vaccination in the WHO European Region. It provides data on which countries have introduced the HPV vaccine as of 2011, the criteria used by countries in their decision making, details on routine and catch-up vaccination programs in various countries, and HPV vaccine coverage rates. It also discusses components of successful HPV vaccination programs and the importance of continuing cervical cancer screening programs alongside vaccination.
This document discusses the implementation of the WHO European Region's Health 2020 policy framework from 2012-2014. It outlines two strategic objectives and four common policy priorities for health. It describes moving from developing the policy to taking action by helping countries update their national health policies and improve public health capacities. The document also discusses promoting the framework, building implementation capacity, supporting country cooperation, and exploring new partnerships to advance the goals of Health 2020 across Europe.
Program expenditure classification - Cristina CLASARA, PhilippinesOECD Governance
The document discusses the Program Expenditure Classification Restructuring (PREXC) approach which aims to simplify the budget structure, link planning and budgeting, and measure performance. It does this by grouping all recurring activities and projects under the programs they contribute to and providing performance indicators for each program objective. This shifts the focus from line-item inputs to the intended outcomes of allocations. It also defines what constitutes a program and provides an example comparing the old and PREXC structures, showing how the PREXC approach organizes budget items by program and associated outcome indicators.
Programme budgeting for health - Edwin Lau, OECD SecretariatOECD Governance
This presentation was made by Edwin Lau, OECD Secretariat, at the 7th meeting of the Joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held at the OECD Conference Centre, Paris, on 14-15 February 2019
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe at the South-eastern Europe Health Ministerial Meeting on Immunization in Podgorica, Montenegro, 20 February 2018
THE GF-TADs INITIATIVE FOR THE GLOBAL CONTROL OF AFRICAN SWINE FEVEREuFMD
African swine fever (ASF) is an infectious disease affecting pigs that has spread globally and poses a major threat to animal health, economies, and food security. The World Organisation for Animal Health and Food and Agriculture Organization of the United Nations developed a Global Initiative to control ASF between 2020-2025 using a theory of change, logical framework, and operational plan. The initiative aims to support global coordination in ASF control through activities implemented under the Global Framework for Transboundary Animal Diseases. Regional expert groups will also play a key role, with continued investment in veterinary services and surveillance needed to feasibly control ASF globally over the long term.
Holmgren redd+ monitoring and information overview 21 march 2011 finaltheREDDdesk
The document discusses monitoring and information requirements for REDD+ programs. It outlines that monitoring is key to meeting UNFCCC requirements, serving national policy needs, and ensuring effective local implementation. Monitoring needs to assess carbon emissions, environmental and social impacts, and governance. Strategic monitoring requires high accuracy while operational monitoring needs full coverage at low cost. The UN-REDD program will develop a monitoring framework and package of tools to support country-level REDD+ monitoring efforts.
TOPIC 1 IMUNIZATION SYSTEMS AND OPERATIONS.pdfChisupa
The document discusses the Expanded Programme on Immunization (EPI), which aims to eradicate and eliminate vaccine-preventable diseases through vaccination programs. It describes the goals and components of EPI, including vaccines, cold chain storage, service delivery, disease surveillance, and social mobilization. The key operations of immunization systems are outlined as vaccine supply and quality, logistics, service delivery, surveillance, and communication. Supporting components that sustain immunization operations are management, sustainable financing, and strengthening human and institutional resources.
This document summarizes discussions from a microbiology focal points meeting on health threats and preparedness. Key points include:
1) The European Social Fund Plus for 2021-2027 aims to strengthen crisis preparedness and response to cross-border health threats.
2) Joint actions like SHARP work to improve implementation of the International Health Regulations and enhance laboratory capacity for detecting pathogens.
3) The Horizon Europe programme will support research and innovation to develop new therapies and diagnostics for infectious diseases.
4) Various Commission DGs are collaborating on initiatives related to laboratory networks, digital health, biosafety, and security to improve EU preparedness for health emergencies.
The National Antibiotic Guidelines provide concise treatment recommendations for common infections to promote rational antibiotic use in the Philippines. A committee was formed to develop the guidelines which consolidate existing evidence and expert consensus. The guidelines cover treatment of various adult and pediatric infections across different clinical settings and healthcare levels. Their goal is to improve patient outcomes while reducing antimicrobial resistance and healthcare costs.
Prevention strategies tackling hepatitis B virus (HBV) in European Union (EU)/European Economic Area (EEA) countries are centred around universal or targeted vaccination programmes.
Poster at ESCAIDE 2016, Stockholm
The document outlines an action plan for the health sector response to HIV in Europe with the vision of ending the AIDS epidemic as a public health threat by 2030. It identifies five strategic directions: (1) using data to guide focused services, (2) prioritizing prevention and treatment interventions, (3) delivering equitable services based on human rights, (4) financing a sustainable response, and (5) stimulating innovation. Fast-track actions are outlined under each strategic direction to strengthen coordination, expand testing and treatment, eliminate transmission, and transition to domestic financing. The draft resolution calls on countries to review strategies, strengthen prevention, ensure commitment and financing, and monitor implementation of the plan.
This document provides an outline and instructions for an education session on hand hygiene for trainers, observers, and healthcare workers. The session aims to raise awareness of key hand hygiene messages and teach the WHO guidelines. It will cover topics like the impact of healthcare-associated infections, transmission risks, and the WHO's hand hygiene implementation strategy. Practical sessions are recommended to demonstrate hand hygiene procedures during patient care.
The document outlines the End TB Strategy developed by the World Health Organization to end the global tuberculosis epidemic. It discusses the burden of TB, progress made, and ongoing challenges. The strategy has three pillars: integrated patient-centered care and prevention, bold policies and supportive systems, and intensified research and innovation. It aims to reduce TB deaths and incidence rates through universal health coverage, new tools, and social protections to reach targets by 2025 and 2035. Progress will be measured using indicators like treatment coverage, success rates, and uptake of new diagnostics.
PROMISE ethics panel final report, October 17, 2012erikanature
Final report of a specially commissioned panel tasked with examining the ethics of the PROMISE trials, which study different drug regimens to prevent mother to child transmission of HIV. The trials are sponsored by the US National Institute of Allergy and Infectious Disease, which commissioned the ethics review.
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCDRIVE research
This document summarizes ECDC's work on influenza vaccine effectiveness studies in Europe. It outlines ECDC's strategic objectives related to influenza, which include improving surveillance information, promoting vaccination, and strengthening pandemic preparedness. The document discusses ECDC's priorities for 2019, which focus on transforming influenza surveillance, monitoring vaccination programs, and pandemic preparedness. It provides details on ECDC's influenza outputs and activities for 2019, including surveillance reports, vaccine effectiveness studies, and preparedness assessments.
GLOBAL STRATEGY FOR MEASLES ELIMINATIONPreetam Kar
The document outlines the presentation of Dr. Preetam Kumar Kar on measles elimination. It discusses:
1. The global burden of measles in 2000 with over 500,000 deaths annually, mostly in developing countries.
2. The goals of the 2012 Global Measles Elimination Strategic Plan to reduce measles mortality by 95% by 2015 and achieve regional elimination in 5 WHO regions by 2020.
3. India's strategy to strengthen routine immunization, conduct supplemental immunization activities, and enhance surveillance to reduce measles cases and meet regional elimination targets.
DOTS is the WHO-recommended strategy for tuberculosis detection and treatment. It involves identifying infectious TB patients through microscopy, observing patients swallowing anti-TB drugs daily for 6-8 months, and regularly monitoring patients' progress. DOTS was launched in Pakistan in 1995 but faced challenges until being expanded nationwide by 2005. While cure rates and coverage increased under DOTS, Pakistan still faces ongoing issues with drug-resistant TB, capacity, and monitoring systems. The updated Stop TB Strategy aims to further improve TB control globally through universal access to diagnosis and treatment.
This document provides information about India's National Immunization Programme (UIP). It discusses the targeted vaccine preventable diseases (VPDs), the history and objectives of the Expanded Programme on Immunization (EPI) and Universal Immunization Programme (UIP). It outlines the national immunization schedule, components of UIP including vaccination of pregnant women and children, and strategies to achieve coverage goals. Coverage levels from surveys are presented. The document also discusses vaccine administration techniques for different vaccines.
Challenges to ensuring sustainable effective vaccination programmes include:
1) Ensuring high vaccination coverage rates by maintaining confidence in vaccines and acceptance among the public.
2) Guaranteeing equal access to vaccination by breaking down economic barriers and reaching underserved groups.
3) Strengthening vaccination monitoring programs and performance by improving surveillance, evaluating vaccine effectiveness over time, and providing ongoing training.
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
EPI Senegal comprehensive multi-year plan for 2012-2016 vencheles23
The document presents Senegal's 2012-2016 Complete Multi-Year Plan for its Expanded Program on Immunisation (EPI), which aims to reduce infant and child mortality and improve maternal health through vaccination and surveillance of targeted diseases. The plan establishes priorities, strategies, and activities to introduce two new vaccines and conduct a meningitis campaign over the five year period, at a total cost of $207 million which is expected to be 99% funded through government and partner support.
The document provides information on Nepal's national immunization program, including its goals, objectives, strategies, and key activities. The program aims to reduce child mortality from vaccine-preventable diseases by achieving and maintaining at least 90% vaccine coverage nationwide. It coordinates immunization services delivered through government health facilities, private providers, and NGOs. Milestones include introducing new vaccines and achieving the eradication of polio and elimination of maternal and neonatal tetanus.
This document outlines core components for infection prevention and control (IPC) programs at both the healthcare facility and national levels. It recommends establishing IPC programs with dedicated staff and resources, developing evidence-based guidelines, providing IPC education and training, conducting HAI surveillance, and implementing multimodal strategies using a combination of interventions to improve IPC practices and reduce healthcare-associated infections and antimicrobial resistance. The core components provide guidance on setting up the organizational structures, key activities, and linkages needed for effective IPC programs.
Massimo Ciotti: ECDC Activities in the Area of PreparednessTHL
This document summarizes a presentation on emergency preparedness and response given by Massimo Ciotti at the One Health Security Conference in Helsinki on October 14-15, 2019. It discusses the European Centre for Disease Prevention and Control's (ECDC) role in supporting EU member states' implementation of preparedness plans for cross-border health threats, including sharing best practices and promoting interoperability between national plans. It also outlines ECDC's strategies and ongoing activities to strengthen country-level preparedness through risk assessment, training, exercises and other capacity building efforts.
Similar to European Vaccine Action Plan (EVAP) (20)
This document summarizes measles and rubella surveillance data from the WHO European Region from March 2021 to February 2022. It finds that 22 countries reported 222 measles cases, with the majority (87%) occurring in 10 countries including Tajikistan, Turkey, Belgium, and Poland. 107 rubella cases were reported by 12 countries, with 96 cases in 5 countries including Poland, Turkey, Ukraine, and Germany. The data also examines case trends over time and genotypes in an effort to monitor elimination goals for these vaccine-preventable diseases.
This document summarizes reported measles cases in the WHO European Region from March 2021 to February 2022. It shows the total number of measles cases and incidence rate per country over this period. The highest numbers of cases were reported in Poland, Germany, Italy, and Ukraine. Overall, there were 222 measles cases reported in March 2021, rising to a peak of 35 cases in October 2021, before declining to 33 cases in February 2022.
The document summarizes measles and rubella surveillance data from the WHO European Region. It provides data on measles and rubella cases, incidence, genotypes, and vaccination coverage from 2021-2022. The top countries for measles and rubella cases in this period are reported, with Turkey, Poland, and Ukraine among those with the highest numbers of measles cases and Poland reporting the most rubella cases.
The document provides an overview of measles and rubella cases and vaccination coverage in the WHO European Region from 2021-2022. It summarizes measles and rubella data for 2021, including the top 10 countries by cases. Turkey had the most measles cases in 2021 while Poland had the most rubella cases. Vaccination coverage for measles-containing vaccines was over 90% from 2010-2021.
The document summarizes measles and rubella surveillance data from the WHO European Region from December 2020 to November 2021. It finds that 148 measles cases were reported in this period, with the majority (89%) occurring in 11 countries including Turkey, France, Poland, and Belgium. 103 rubella cases were reported in the same period, with over 90% concentrated in 5 countries including Italy, Germany, Turkey, and Ukraine. Overall measles and rubella cases have declined in the region since 2018 but surveillance and vaccination efforts need to remain vigilant to prevent further outbreaks.
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
The document summarizes measles and rubella surveillance data from the WHO European Region from October 2020 to September 2021. It finds that Turkey, Ukraine, and Poland reported the most measles cases, with Turkey reporting 35 cases. It also finds that Azerbaijan, Germany, Turkey, Ukraine, and Poland reported the most rubella cases, with Poland reporting 47 cases. Overall, measles and rubella cases have decreased in the region since 2019, but ongoing vaccination efforts are still needed to eliminate both diseases.
The document provides information on measles and rubella cases in the WHO European Region from September 2020 to August 2021. It summarizes that Turkey, Ukraine, and Poland reported the most measles cases, while Poland, Ukraine, and Turkey reported the most rubella cases. Overall measles and rubella cases have declined compared to previous years but outbreaks still occur periodically in some countries. The document also provides links to additional measles and rubella surveillance resources on the WHO website.
The document provides an overview of measles and rubella cases in the WHO European Region from August 2020 to July 2021. It summarizes measles and rubella data, including the number of reported cases by country, genotype information, and monthly trends over multiple years. Turkey had the highest number of measles cases while Poland had the most rubella cases. Measles cases were highest among unvaccinated children under 5 years old.
The document summarizes measles and rubella surveillance data from the WHO European Region from July 2020 to June 2021. It finds that for measles, Turkey, Ukraine, Belgium, Poland and France reported the most cases, with Turkey reporting 30 cases. For rubella, Italy, Turkey, Germany, Ukraine and Poland reported most of the 80 total cases. The number of measles cases decreased from 2020 to 2021 while the number of rubella cases remained low. Vaccination coverage and outbreaks varied by country.
The document provides measles and rubella surveillance data for the WHO European Region from May 2020 to April 2021. It shows that:
- Kazakhstan reported the highest number of measles cases, while Poland, France, and others also reported cases.
- For rubella, Poland reported the highest number of cases between May 2020 to April 2021, while Italy, Turkey, Germany and Ukraine also reported cases.
- Both measles and rubella cases were highest in 2020 compared to previous years, though rubella cases remained low overall, with 188 cases reported for 2020.
Uzbekistan and Kazakhstan reported the highest numbers of measles cases between April 2020-March 2021, with 446 and 423 cases respectively. Overall, 1,511 measles cases were reported in this period in the WHO European Region, with 96% occurring in the top 10 reporting countries. For rubella, 86 total cases were reported between April 2020-March 2021, with 97% found in the top 5 countries of Italy, Turkey, Germany, Ukraine, and Poland.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
1. European Vaccine Action Plan
(EVAP)
Dr Nedret Emiroglu
Deputy Director, Division of Communicable Diseases,
Health Security and Environment
Special Representative of the Regional Director on
the Millennium Development Goals and Governance
2. Immunization coverage for selected antigens,
WHO European Region, 1990–2013
100
90
80
70
60
50
40
30
20
10
0
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
Source: WHO/United Nations Children’s Fund (UNICEF) adjusted coverage estimates.
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Coverage (% )
Year
DTP3
HepB3
Hib3
Pol3
dtp3
hepb3
hib3
pol3
Legend: 3 doses of vaccines
for diphtheria, tetanus and
pertussis (DTP3), hepatitis
B (HepB3), Haemophilus
influenzae type B (Hib3)
and poliomyelitis (Pol3).
3. Building on achievements
• Political commitment
• Addressing immunity gaps
• Vaccine hesitancy and refusal
• Integration with other health
interventions
• Alignment with changes in
health systems
• Sustainable access to vaccines
and predictable funding
5. 2013 2014
EVAP timeline
1st draft 2nd draft
RC64 version
RC64
September
2014
Outline
RC63
September
2013
Regional consultation (face to face and web based)
European Technical Advisory Group of Experts on Immunization (ETAGE)
Engagement of the Standing Committee
of the Regional Committee (SCRC)
8. EVAP objectives
1. All countries commit to immunization
as a priority
2. Individuals understand the value of
immunization services and vaccines and
demand vaccination
3. The benefits of immunization are equitably
extended to all people through tailored,
innovative strategies
4. Strong immunization systems are an integral
part of a well-functioning health system
5. Immunization programmes have sustainable
access to predictable funding and high-quality
supply
10. EVAP monitoring and evaluation framework
• Aligned with the global
framework
• Using existing mechanism
and data (joint reporting
form, with no new
indicators or variables)
• Secretariat to prepare
annual progress reports
on implementation
11. Draft resolution
Regional Committee adopts EVAP
and urges Member States:
• to commit to immunization as a
priority;
• to harmonize their national
immunization plans with EVAP;
and
• to provide information on the
risks and benefits.
12. Draft resolution
Requests the Regional Director:
• to support the implementation of
EVAP;
• to provide leadership and call for
resources;
• to provide guidance in targeting
specific high-risk groups, including
those hesitant about vaccination;
and
• to monitor and evaluate progress.